Research Active Practice

Award winning research

Our research team were awarded Primary Care Research Team of the Year at the North West Coast Research and Innovation Awards 2023! The team received the award for demonstrating how research is being delivered in Lancaster and for making more research opportunities available to the local community.

The team also received a commendation from the Royal College of General Practitioners and NIHR Clinical Research Network Research Awards 2023. In 2022, they were shortlisted for Research Delivery Team of the Year at the North West Coast Research and Innovation Awards. They have also been awarded a Certificate of Achievement by the National Institute for Health and Care Research for their contributions to NHS research studies over the last year!

We are a ‘research active’ practice which means we take part in a wide range of studies. As of August 2019, LMP has been officially granted Research Ready accreditation to reflect our commitment to high quality research. Research helps to enhance knowledge on how to treat conditions, prevent illnesses and form the best care across society and within the NHS. Volunteering to get involved may mean filling in questionnaires, surveys, talking to one of the research team, or trialling a new treatment or drug.

Our base is at the University site, but we are active across all sites. We are a small team but growing, and want to get as many patients involved in research as possible.

A strict code of conduct is at the heart of all of our work to make sure data is always confidential.

More information on the GDPR guidelines that we follow.

If you would like to talk to one of our research nurses about participating in a study, or have a query about research, you can call 01524 518667 on Tuesdays and Wednesdays.

You can also find out more information about research at the National Institute for Health Research website.

Active Studies


The study aims to find out whether taking a low dose of amitriptyline soon after getting shingles can prevent pain associated with shingles.


DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS.


The DEFINE study will help health care professionals in GP surgeries provide a more personalised approach to managing patients’ asthma by using FeNO to guide decisions about their treatment.


The Genetic Links to Anxiety and Depression (GLAD) Study is a project set up to support studies exploring risk factors for depression and/or anxiety.

Health Checks for Autistic Adults

The Health Checks for Autistic Adults study aims to design a biopsychosocial health check for autistic adults for use by NHS Primary Care professionals and carry out an evaluation of its use.    


PANORAMIC is a national trial sponsored by Oxford University aimed at finding new antiviral treatments for COVID-19.


The study aims to assess a new relief inhaler for mild asthma.

Take a Test

Enter the code P81002 to order a free surveillance PCR test for COVID-19, flu or RSV.


In this study we aim to evaluate multiple UTI rapid tests in parallel at GP surgeries and compare new tests to standard UTI tests.

RCGP Research and Surveillance Centre

Internationally renowned source of information, analysis and interpretation of primary care data.


We are not recruiting into follow-up studies.



FLUENZ TETRA Safety Survey

Published Findings

Here you can see the published findings for the studies that Lancaster Medical Practice have taken part in.


Over 50 LMP patients took part in this study, which looked to determine the 2-year outcomes of patients newly diagnosed with atrial fibrillation (AF), and the effectiveness of oral anticoagulants.

The study concluded: The data support a benefit of anticoagulation in reducing stroke and death, without an increased risk of a major bleed in patients with new-onset AF. Anticoagulation treatment in patients at high risk of stroke who are not receiving anticoagulation may further improve outcomes.

Read the full research article

All Heart

60 of our patients took part in this study from 2017-2021 which aimed to determine whether allopurinol therapy improves major cardiovascular outcomes in patients with ischaemic heart disease.

The study concluded: In this large, randomised clinical trial in patients aged 60 years or older with ischaemic heart disease but no history of gout, there was no difference in the primary outcome of non-fatal myocardial infarction, non-fatal stroke, or cardiovascular death between participants randomised to allopurinol therapy and those randomised to usual care.

Read the full research article

Page last reviewed: March 5th, 2024
Next review due: August 5th, 2024